Moneycontrol
HomeNewsBusinessEconomyInterview | Economic impact of third wave of COVID likely to be less than that of second wave, lockdowns: Chief Economic Advisor
Trending Topics

Interview | Economic impact of third wave of COVID likely to be less than that of second wave, lockdowns: Chief Economic Advisor

Krishnamurthy Subramanian tells Moneycontrol in an interview that credit guarantee loans to small borrowers and MSMEs were more targeted and effective than any direct cash transfer. The government's budget plank of higher capital expenditure will have a substantial multiplier effect on the economy, he said.

July 15, 2021 / 19:11 IST
Story continues below Advertisement
Chief Economic Adviser Krishnamurthy V Subramanian

Chief Economic Advisor Krishnamurthy Subramanian says the economic impact of the third wave is expected to be much softer than that of the lockdown last year, and the second COVID wave. This is because vaccination numbers are rising and the states and the Centre have learnt to contain lockdowns better.

“So, in itself, the health impact of the third wave may be much less than the second wave. The second wave’s economic impact was much lower than the first wave. When you take all of them into account, I think the third wave’s economic impact may not be very large,” Subramanian said in an interview with Moneycontrol.

Story continues below Advertisement

Subramanian also said that the credit guarantee schemes to small individual borrowers as well as various sectors can be treated as quasi-income support, while effectively ruling out fiscal measures, apart from the ones announced in the budget, which, he said, will have a much larger multiplier effect on economic activity, consumption and job creation.

Excerpts:

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show